Nkarta to Participate in an April Investor Conference
Provided By GlobeNewswire
Last update: Apr 1, 2025
SOUTH SAN FRANCISCO, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conference:
Read more at globenewswire.com
